<DOC>
	<DOCNO>NCT02646007</DOCNO>
	<brief_summary>Kienböck 's disease characterize avascular necrosis lunate wrist bone , usually progressive without treatment . Cell therapy useful treatment degenerate bone mesenchymal stromal/stem cell best candidate kind treatment . This study examine lunate core decompression combination implantation autologous bone marrow derive mesenchymal stromal cell Its treatment potential . Bone decompression combination implantation autologous bone marrow derive mesenchymal stromal/stem cell do 30 patient Kienböck disease . The patient follow 2weeks , 3months , 6m 12 month implantation . The Spss ( v16 ) software use data analysis .</brief_summary>
	<brief_title>Autologous Bone Marrow Derived Mesenchymal Stromal Cells Transplantation ( BM-MSC ) Kienbock 's Disease</brief_title>
	<detailed_description>Kienböck 's disease characterize avascular necrosis lunate wrist There probably single cause avascular necrosis lunate . Its origin may involve multiple factor , blood supply ( artery ) , blood drainage ( vein ) , skeletal variation . Current treatment : early phase observation . In advanced phase surgical technique bone decompression . A potential therapeutic strategy would cell therapy , A source cell regenerative potential could mesenchymal stem cell ( MSCs ) . The investigator evaluate safety efficacy implantation autologous BM-MSC ( bone marrow-derived mesenchymal stromal cell ) 30 patient Kienböck 's disease combination bone decompression surgery . These patient follow data analyze spss ( v16 ) .</detailed_description>
	<mesh_term>Osteonecrosis</mesh_term>
	<criteria>Kienböck 's disease without response conservative treatment ( physical medical ) 6 month Both gender Visual Analogue Scale 4 high Hematological biochemical analysis significant alteration contraindicate intervention The patient able understand nature study Informed write consent patient Age 65 18 legally dependent Infection sign positive serology HIV , hepatitis syphilis Allergy gentamicin , bovine , cattle horse serum Pregnancy lactate Pregnancy breastfeed Neoplasia Immunosuppression Participation another clinical trial treatment another investigational product within 30 day prior inclusion study Other condition may , accord medical criterion , discourage participation study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Autologous Cell therapy Kienböck 's disease</keyword>
	<keyword>bone marrow derive mesenchymal stromal/stem cell</keyword>
</DOC>